Cho H
Front Mol Biosci. 2025; 11():1527313.
PMID: 39845903
PMC: 11753208.
DOI: 10.3389/fmolb.2024.1527313.
Yablonska S, Strohlein C, Baranov S, Yeh S, Patel A, Singh T
J Neurosci. 2025; 45(8).
PMID: 39779371
PMC: 11841767.
DOI: 10.1523/JNEUROSCI.1254-24.2024.
Moldovean-Cioroianu N
Int J Mol Sci. 2024; 25(12).
PMID: 38928495
PMC: 11204371.
DOI: 10.3390/ijms25126789.
Zhang Z, Gehin C, Abriata L, Dal Peraro M, Lashuel H
ACS Chem Neurosci. 2024; 15(12):2408-2419.
PMID: 38752226
PMC: 11191595.
DOI: 10.1021/acschemneuro.4c00091.
Gamage Y, Pan J
Biophysica. 2024; 3(4):582-597.
PMID: 38737720
PMC: 11087071.
DOI: 10.3390/biophysica3040040.
BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease.
Gu Y, Pope A, Smith C, Carmona C, Johnstone A, Shi L
Neurobiol Dis. 2024; 195:106502.
PMID: 38608784
PMC: 11890210.
DOI: 10.1016/j.nbd.2024.106502.
Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases.
Reed A, Mitchell W, Alexandrescu A, Alder N
Front Physiol. 2023; 14:1263420.
PMID: 38028797
PMC: 10652799.
DOI: 10.3389/fphys.2023.1263420.
HD and SCA1: Tales from two 30-year journeys since gene discovery.
Thompson L, Orr H
Neuron. 2023; 111(22):3517-3530.
PMID: 37863037
PMC: 10842341.
DOI: 10.1016/j.neuron.2023.09.036.
Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington's disease via the nasal-brain route.
Smriti , Singla M, Gupta S, Porwal O, Binjawhar D, Sayed A
Front Pharmacol. 2023; 14:1218625.
PMID: 37492081
PMC: 10364480.
DOI: 10.3389/fphar.2023.1218625.
The structure of pathogenic huntingtin exon 1 defines the bases of its aggregation propensity.
Elena-Real C, Sagar A, Urbanek A, Popovic M, Morato A, Estana A
Nat Struct Mol Biol. 2023; 30(3):309-320.
PMID: 36864173
DOI: 10.1038/s41594-023-00920-0.
Mechanistic Insight into the Suppression of Polyglutamine Aggregation by SRCP1.
Haver H, Wedemeyer M, Butcher E, Peterson F, Volkman B, Scaglione K
ACS Chem Biol. 2023; 18(3):549-560.
PMID: 36791332
PMC: 10023506.
DOI: 10.1021/acschembio.2c00893.
HSF1 and Its Role in Huntington's Disease Pathology.
Kim H, Gomez-Pastor R
Adv Exp Med Biol. 2022; 1410:35-95.
PMID: 36396925
DOI: 10.1007/5584_2022_742.
Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease.
Seefelder M, Klein F, Landwehrmeyer B, Fernandez-Busnadiego R, Kochanek S
J Huntingtons Dis. 2022; 11(3):227-242.
PMID: 35871360
PMC: 9484127.
DOI: 10.3233/JHD-220543.
Oxidation Promotes Distinct Huntingtin Aggregates in the Presence and Absence of Membranes.
Adegbuyiro A, Stonebraker A, Sedighi F, Fan C, Hodges B, Li P
Biochemistry. 2022; 61(14):1517-1530.
PMID: 35759798
PMC: 9296575.
DOI: 10.1021/acs.biochem.2c00212.
Molecular Pathophysiological Mechanisms in Huntington's Disease.
Jurcau A
Biomedicines. 2022; 10(6).
PMID: 35740453
PMC: 9219859.
DOI: 10.3390/biomedicines10061432.
Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties.
Riguet N, Mahul-Mellier A, Maharjan N, Burtscher J, Croisier M, Knott G
Nat Commun. 2021; 12(1):6579.
PMID: 34772920
PMC: 8589980.
DOI: 10.1038/s41467-021-26684-z.
Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.
Sawant N, Morton H, Kshirsagar S, Reddy A, Reddy P
Mol Neurobiol. 2021; 58(12):6350-6377.
PMID: 34519969
DOI: 10.1007/s12035-021-02556-x.
Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: An opinion.
Kumar V, Singh A
EXCLI J. 2021; 20:1086-1090.
PMID: 34267617
PMC: 8278213.
DOI: 10.17179/excli2021-3670.
Membrane Interactions Accelerate the Self-Aggregation of Huntingtin Exon 1 Fragments in a Polyglutamine Length-Dependent Manner.
Marquette A, Aisenbrey C, Bechinger B
Int J Mol Sci. 2021; 22(13).
PMID: 34201610
PMC: 8268948.
DOI: 10.3390/ijms22136725.
Mitochondrial membranes modify mutant huntingtin aggregation.
Adegbuyiro A, Sedighi F, Jain P, Pinti M, Siriwardhana C, Hollander J
Biochim Biophys Acta Biomembr. 2021; 1863(10):183663.
PMID: 34089719
PMC: 8328955.
DOI: 10.1016/j.bbamem.2021.183663.